The Dow Jones advanced by 3.85% to 24,567 after Moderna’s positive result of an initial phase COVID-19 vaccine trial and the Fed’s unlimited relief measures to shield the U.S. economy. Back in the domestic economy, investors closely eye on May’s BI-7DRRR announced today.
COVID-19 Relaxed Tax lessen burden weighing on retailers
Growth of Fed Balance Sheet Slow
COVID-19 wreaks all sectors, but we pencil in GGRM to be capable posting 1Q20 positive performance and stable cigarette consumption albeit the soft consumption. Thus, NHKSI recommends GGRM as this week’s preferred stock estimated to reach the price target of IDR61,800 based on a 15.3x P/E trailing band.
The Dow Jones rallied by 0.25% to 23,685 due to the U.S. more-disappointing-than estimate retail sales and the U.S. attempts to hold back Chinese Huawei Technologies using American technology. In the domestic realm, BPS recorded trade balance deficits of USD350 million in April 2020 or much lower than deficits in April 2019.
Financial system stability is at risks because corona wreaking havoc leave commercial activities dysfunction and throw Indonesia’s economy disarray.
NPL ratio in March 2020 was higher than NPL in December 2019. Transportation, manufacturing industry, trade, and consumption credit sectors contributed most to March’s higher NPL.
April’s 20.5 million laid-off workers to hit 14.7% or the second soaring level after post-World War II lay-off give a hint of the U.S. Economy
The Dow Jones rebound by 1.62% to 23,625 due to the rally in JP Morgan (+4.10%) and Citigroup (+3.55%) and market’s optimism about the U.S. economic outlook.
